Glaukos
GKOS----
Glaukos (GKOS)
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retin...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Glaukos Analyst Rating
View MoreForecast & Rating
Jul 17, 2026Price forecast
$165.007.44%
Forecast & RatingStrong buy
13analysts
- Strong buy76.92%
- Buy23.08%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 21 at 03:27 PM
Glaukos CFO Alex R. Thurman disposes of USD 1.6 million in common shares
- benzinga_article · Jul 21 at 12:35 PM
10 Health Care Stocks With Whale Alerts In Today’s Session
- Market Beat · Jul 17 at 08:00 AM
Stifel Nicolaus Forecasts Strong Price Appreciation for Glaukos (NYSE:GKOS) Stock
- PUBT · Jul 13 at 07:05 PM
Glaukos CFO Alex R. Thurman sells 10,000 shares for $1.55 million
- rttnews · Jul 13 at 03:59 AM
Returns Matter: NUTX +214%, CORT +145%, GKOS +97% - Were These Biotech Stocks In Your Portfolio?
- PUBT · Jul 8 at 07:55 PM
Glaukos Chief Development Officer Tomas Navratil disposes of 716 shares for $99,571.96
